These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1685179)

  • 1. Therapeutic effect of ursodeoxycholic acid on early-stage primary biliary cirrhosis.
    Kao JH; Lai MY; Lin JT; Yang PM; Sheu JC; Chen DS; Sung JL; Wang TH
    J Formos Med Assoc; 1991 Oct; 90(10):970-4. PubMed ID: 1685179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late stage disease.
    Kneppelhout JC; Mulder CJ; van Berge Henegouwen GP; de Vries RA; Brandt KH
    Neth J Med; 1992 Aug; 41(1-2):11-6. PubMed ID: 1407234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
    Corpechot C; Abenavoli L; Rabahi N; Chrétien Y; Andréani T; Johanet C; Chazouillères O; Poupon R
    Hepatology; 2008 Sep; 48(3):871-7. PubMed ID: 18752324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease.
    Floreani A; Zappalà F; Mazzetto M; Naccarato R; Plebani M; Chiaramonte M
    Dig Dis Sci; 1994 Jan; 39(1):9-14. PubMed ID: 8281873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a short-term, randomized, double-blind controlled, cross-over study with long-term follow up.
    Hwang SJ; Chan CY; Lee SD; Wu JC; Tsay SH; Lo KJ
    J Gastroenterol Hepatol; 1993; 8(3):217-23. PubMed ID: 8100153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic effects of ursodeoxycholic acid in primary biliary cirrhosis.
    Leevy CB; Holt J; Buniak B
    J Assoc Acad Minor Phys; 1993; 4(1):30-2. PubMed ID: 8425102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis.
    Wouters RS; Bos LP; Engels LG
    Neth J Med; 1990 Aug; 37(1-2):21-3. PubMed ID: 2215828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
    Batts KP; Jorgensen RA; Dickson ER; Lindor KD
    Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.
    Poupon RE; Eschwège E; Poupon R
    J Hepatol; 1990 Jul; 11(1):16-21. PubMed ID: 1975819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome.
    Corpechot C; Chazouillères O; Poupon R
    J Hepatol; 2011 Dec; 55(6):1361-7. PubMed ID: 21703194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observation on therapeutic efficacy of ursodeoxycholic acid in Chinese patients with primary biliary cirrhosis: a 2-year follow-up study.
    Zhu J; Shi Y; Zhou X; Li Z; Huang X; Han Z; Wang J; Wang R; Ding J; Wu K; Han Y; Fan D
    Front Med; 2013 Jun; 7(2):255-63. PubMed ID: 23179137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
    Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
    Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
    Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A two-year follow-up study on the efficacy of ursodeoxycholic acid on primary biliary cirrhosis in different stages].
    Zhu JY; Li ZS; Yan W; Wang JH; Zhou XM; Wang RA; Huang XF; Shi YQ; Dong XY; Han ZY; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):735-9. PubMed ID: 21059288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid.
    Takeuchi Y; Ikeda F; Fujioka S; Takaki T; Osawa T; Yasunaka T; Miyake Y; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K; Itoshima T
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1395-401. PubMed ID: 21443659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
    Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
    Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.